Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Diabetic Kidney Disease Market Growth in 2025?

In recent times, the growth rate of the diabetic kidney disease market size has been steadily increasing. It is projected to escalate from $2.67 billion in 2024 to $2.81 billion in 2025, marking a compound annual growth rate (CAGR) of 5.2%. The substantial growth in the preceding years can be credited to an improved comprehension of diabetes-related complications, technological advancement in diagnostic methods, the introduction of ace inhibitors and arbs, as well as the execution of clinical trials and treatment guidelines. Also, disease management protocols have significantly influenced this growth.

What Is the Forecast for the Diabetic Kidney Disease Market Size Through 2029?

In the coming years, the diabetic kidney disease market is anticipated to experience a significant escalation. By 2029, it is projected to reach $3.56 billion, with a compound annual growth rate (CAGR) of 6.1%. Several factors contribute to this anticipated growth during the forecast period, such as advancements in personalized medicine and biomarker development, an increasing incidence of diabetes worldwide, efforts to enhance disease modification therapies, development in telehealth and remote care, and changes in healthcare policy and reimbursement. During the forecast period, notable trends will include progress in renal replacement therapies, the application of a precision medicine approach, emphasis on early detection and diagnosis, therapeutic advancements, and a rise in the management of comorbidities.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

What are the Key Market Players in Diabetic Kidney Disease Market and How They’re Evolving?

Major companies operating in the diabetic kidney disease market include AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited

What Are the Primary Growth Drivers in the Diabetic Kidney Disease Market?

The escalating incidence of chronic kidney disease is predicted to boost the expansion of the diabetic kidney disease market. Chronic kidney disease (CKD) is a persistent condition characterized by the gradual loss of kidney function, leading to complications like high blood pressure, anemia, and bone diseases. The treatment for CKD necessitates diagnostic and treatment services, which in turn spur the growth of the diabetic kidney disease market. For instance, in June 2023, Kidney Research UK, a renowned UK charity, revealed that about 7.2 million individuals in the United Kingdom, or over 10% of the population, suffer from CKD. Of this populace, 3.25 million are dealing with the most acute stages of the disease, while approximately 3.9 million are at the initial, often undiagnosed and symptomless, stages. Projections suggest that by 2033, the total number of chronic renal disease patients in the United Kingdom could escalate to 7.61 million. Thus, the surging prevalence of chronic kidney disease is steering the diabetic kidney disease market towards further progression.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9932&type=smp

What Are the Leading Segments in the Global Diabetic Kidney Disease Industry?

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease

What Are the Key Market Trends in the Diabetic Kidney Disease Industry?

The surge in technological advances is a trend garnering momentum in the diabetic kidney disease sector. Companies in the diabetic kidney disease arena are leveraging cutting-edge technologies to maintain their market standing. For example, US firm Bloom Diagnostics, involved in diagnostics and healthcare devices, unveiled the Bloom Kidney Test in August 2022. This novel tool is assimilated into the Bloom Smart System. The diagnostic tool, Bloom Kidney Test, gauges kidney health by determining the levels of cystatin C – a trustworthy metric of kidney function. It sorts kidney function into three divisions: regular, slightly decreased, and diminished. The Bloom Smart System uses AI-based algorithms and Artificial Intelligence technology to amalgamate test results with other pertinent health details such as lifestyle, medical background, and the patient’s symptoms.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

What Is the Regional Outlook for the Diabetic Kidney Disease Market?

North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9932

This Report Delivers Insight On:

1. How big is the diabetic kidney disease market, and how is it changing globally?

2. Who are the major companies in the diabetic kidney disease market, and how are they performing?

3. What are the key opportunities and risks in the diabetic kidney disease market right now?

4. Which products or customer segments are growing the most in the diabetic kidney disease market?

5. What factors are helping or slowing down the growth of the diabetic kidney disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model